ZHONGXING LIAO to Tomography, X-Ray Computed
This is a "connection" page, showing publications ZHONGXING LIAO has written about Tomography, X-Ray Computed.
Connection Strength
0.464
-
Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):278-87.
Score: 0.102
-
Atlas ranking and selection for automatic segmentation of the esophagus from CT scans. Phys Med Biol. 2017 Nov 14; 62(23):9140-9158.
Score: 0.048
-
Cardiac atlas development and validation for automatic segmentation of cardiac substructures. Radiother Oncol. 2017 01; 122(1):66-71.
Score: 0.045
-
NSCLC tumor shrinkage prediction using quantitative image features. Comput Med Imaging Graph. 2016 Apr; 49:29-36.
Score: 0.042
-
A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced esophagitis. J Appl Clin Med Phys. 2013 May 06; 14(3):4195.
Score: 0.035
-
Outcomes with esophageal cancer radiation therapy. J Thorac Oncol. 2009 Jul; 4(7):880-8.
Score: 0.027
-
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):967-71.
Score: 0.026
-
Effects of respiration-averaged computed tomography on positron emission tomography/computed tomography quantification and its potential impact on gross tumor volume delineation. Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):890-9.
Score: 0.025
-
New Data-Driven Gated PET/CT Free of Misregistration Artifacts. Int J Radiat Oncol Biol Phys. 2021 04 01; 109(5):1638-1646.
Score: 0.015
-
The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis. Med Phys. 2018 Nov; 45(11):5317-5324.
Score: 0.013
-
Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer. Sci Rep. 2017 04 03; 7(1):588.
Score: 0.012
-
7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial. Cancer. 2017 Aug 15; 123(16):3031-3039.
Score: 0.012
-
Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys. 1995 Jul 30; 32(5):1359-70.
Score: 0.010
-
Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors. Radiology. 2016 Jan; 278(1):214-22.
Score: 0.010
-
Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients. Radiother Oncol. 2015 Mar; 114(3):367-72.
Score: 0.010
-
Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case series. Pract Radiat Oncol. 2015 Jul-Aug; 5(4):e345-53.
Score: 0.010
-
Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):834-42.
Score: 0.010
-
Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer. J Thorac Oncol. 2009 Feb; 4(2):179-84.
Score: 0.007
-
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2007 Nov; 84(5):1685-92; discussion 1692-3.
Score: 0.006